Among seven new medicines recommended for approval by the EMA's human medicine advisory committee at its latest meeting is ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe ...

With a fresh endorsement from the FDA, the last of five major drug approvals has fallen into place for GSK in 2025. | Tuesday ...

The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an ...

The parents of a 13-year-old girl who died after an asthma attack led to a cardiac arrest have said they fear "other families ...

Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...

While yoga is essentially a physical act, it is more about the science of enlivening the body, mind, and breath in perfect ...

The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...

Asthma medication plays a key role in how well you control your condition. There are two main types of treatment, each geared toward a specific goal. Controller medications are the most important ...

Maryland lawmakers introduce the Affordable Inhalers and Nebulizers Act to reduce the cost of inhalers and expand Medicare ...